Atrial Fibrillation (AFib): What It Is, Symptoms, Stroke Risk, and When to See a Doctor

Short Answer

Atrial fibrillation (AFib or AF) is an irregular, often rapid heart rhythm that starts in the upper chambers of the heart — the atria. In a steady rhythm, the atria squeeze in a coordinated way before blood moves into the lower chambers. In AFib, the electrical signals become chaotic, so the atria quiver instead of pumping cleanly; your pulse may feel uneven, fast, fluttery, or "off," and blood may not move through the heart as efficiently (Mayo Clinic).

It is important because atrial fibrillation is "the most common sustained cardiac arrhythmia, affecting millions globally and significantly increasing the risk of stroke, heart failure, and mortality" (*Indian Journal of Clinical Cardiology*, 2026, DOI 10.1177/26324636251414493).

AFib becomes more common with age. Large cohort data and the 2023 ACC/AHA/ACCP/HRS guideline support the common "about 1 in 3" lifetime-risk framing — for example, Framingham-based research estimated lifetime risk around 31%–37%, while the guideline reports lifetime risk around 30%–40% in White individuals, with lower estimates reported in some other populations (Framingham Heart Study cohort, *BMJ* 2018, PMC5917175). The two things that matter most if your pulse feels irregular are simple but important: AFib needs ECG-based confirmation — not just a sensation or a wellness-app signal — and, if AFib is present, your stroke risk should be assessed and managed with a clinician (2023 ACC/AHA/ACCP/HRS guideline, *Circulation*).

What is atrial fibrillation?

Atrial fibrillation is an irregular heart rhythm that starts in the heart's upper chambers — the atria. In a normal heartbeat, the sinus node acts like the heart's built-in pacemaker: it sends an electrical signal across the atria, the signal pauses briefly at the AV node, then travels into the ventricles so the lower chambers can squeeze and pump blood in a coordinated way. In AFib, that clean sequence breaks down. Electrical signals in the atria become chaotic, so the atria fibrillate — they quiver instead of contracting firmly — and too many disorganized signals reach the ventricles. The result is a heartbeat that feels uneven and is often fast, because the lower chambers are being prompted in an irregular pattern rather than a steady rhythm (Mayo Clinic).

That's why AFib can feel so strange in your body: your pulse may race, pause, flutter, or feel "off," not because the whole heart has stopped working, but because the timing system above the ventricles is no longer giving the ventricles a smooth, regular beat to follow. Medically, AFib is a supraventricular arrhythmia — "supra" means above, so the rhythm problem originates above the ventricles, in the atria or other structures involved in upper-heart electrical conduction (StatPearls/NCBI).

For context on where it sits among arrhythmias: atrial fibrillation is "the supraventricular tachy-arrhythmia most commonly detected in the general population, with significant sex-related differences in epidemiology, pathophysiology, and treatment outcomes" (*Biomedicines*, 2025, PMC12561679).

Types of AFib

Clinicians classify AFib mainly by its pattern over time: how long episodes last, whether they stop on their own, and whether you and your clinician are still trying to restore a normal rhythm. The 2023 ACC/AHA/ACCP/HRS guideline uses the key thresholds below: within 7 days for paroxysmal AFib, more than 7 days for persistent AFib, and more than 12 months for long-standing persistent AFib (2023 ACC/AHA/ACCP/HRS guideline).

• Paroxysmal — Episodes come and go. They stop within 7 days, either on their own or with clinician-directed help. Symptoms may last minutes to hours for some people, but AFib can also happen without obvious symptoms.

• Persistent — AFib is continuous for more than 7 days and usually does not reset to a normal rhythm by itself. Clinicians may use rhythm-restoring treatment when appropriate.

• Long-standing persistent — Continuous AFib has lasted more than 12 months.

• Permanent — AFib is ongoing, and you and your clinician have made a shared decision to stop trying to restore or maintain normal sinus rhythm. This is a care decision, not a separate "worse" rhythm by itself.

These distinctions are clinically real, not cosmetic. A short, intermittent episode can feel dramatic — or you may not feel it at all — and early paroxysmal AFib can be easy to miss if your heart is back in normal rhythm by the time you're examined. That's why clinicians often use ECG-based monitoring over time when AFib is suspected but not captured in a brief visit (Mayo Clinic: Diagnosis & treatment). Newer research continues to study how different AFib patterns relate to changes in heart function; for example, "comparative data on myocardial strain between paroxysmal AF (PAF) and persistent AF (PsAF) remain limited" (*European Journal of Medical Research*, 2025, PMC12512781).

Symptoms of AFib

AFib symptoms can feel obvious — or surprisingly vague. You might notice palpitations: a fluttering, pounding, "fish flopping," or racing feeling in your chest. Your pulse may feel irregular, uneven, or too fast. You may also feel unusually tired, short of breath, dizzy, lightheaded, weaker than usual, or less able to exercise. Some people feel chest discomfort or chest pain. These are common symptom patterns described by major medical sources, but they don't all have to appear at once — and symptoms can come and go (Mayo Clinic).

The key point: AFib can be silent. You can have atrial fibrillation and not feel a racing heart, not feel fluttering, and not know anything is wrong. That happens because AFib is defined by an irregular rhythm in the heart's upper chambers — not by how dramatic the symptoms feel. Some people only learn about it when an ECG, a monitor, or a medical visit catches the rhythm (CDC: About Atrial Fibrillation).

Silent AFib matters because these episodes, "although often asymptomatic … are associated with a higher risk of clinical atrial fibrillation (AF), stroke, and heart failure" (*narrative review of subclinical AF*, 2026, PMC12841777), and "subclinical paroxysmal atrial fibrillation (AF) is often undetected by conventional screening strategies, until complications emerge" (*scoping review*, 2026, PMC12843910). In plain language: not feeling AFib does not automatically mean it is harmless. AFib can reduce how smoothly blood moves through the heart, and it can raise the risk of clots and stroke, which is why a clinician-confirmed diagnosis matters.

You can also have AFib with a heart rate that looks "normal" on a watch or feels slower than expected. AFib is a rhythm problem first: the beat is irregular. The ventricular rate — the number you see as beats per minute — can be fast, near your usual range, or slow depending on how signals travel through the AV node, age-related conduction changes, and medications that slow heart rate. So a normal or low heart rate reading does not rule out AFib if the rhythm is irregular or you have concerning symptoms (NCBI Bookshelf).

Why AFib raises stroke risk

In atrial fibrillation, the upper chambers of your heart don't squeeze in a clean, coordinated way. They quiver. That matters because blood moves best when the heart muscle contracts and pushes it forward; when the atria are chaotic, blood can slow down and pool, especially in a small pouch off the left atrium called the left atrial appendage. In AFib, many clots that form in the left atrium start there. If a clot leaves the heart, travels through the bloodstream, and blocks an artery in the brain, that's a stroke. This is why stroke prevention sits at the center of AFib care, even when the heartbeat itself feels only mildly "off" (Cleveland Clinic: Left Atrial Appendage Closure).

The association is well established: "atrial fibrillation (AF) often coexists with hypertension in the elderly and multiplies the risk of stroke and death" (*Journal of Hypertension*, 2019, DOI 10.1097/HJH.0000000000002201).

A commonly cited estimate is that AFib raises the risk of stroke by about five-fold compared with not having AFib. Your individual risk can be much lower or higher than that headline number, which is why clinicians don't judge stroke risk from the rhythm label alone. The 2023 ACC/AHA/ACCP/HRS guideline describes clinical stroke-risk scores as part of AFib care and notes that CHA₂DS₂-VASc is generally the preferred and most validated score; it is used to estimate annual stroke risk and inform decisions about stroke-prevention treatment (2023 ACC/AHA/ACCP/HRS guideline).

CHA₂DS₂-VASc is a clinician-scored checklist, not something you're expected to calculate in your head during a palpitation. It looks at the main risk factors that make a clot-related stroke more likely: congestive heart failure, hypertension, age, diabetes, prior stroke or TIA or thromboembolism, vascular disease, and sex category. Clinicians use that risk picture, together with bleeding risk and your overall health, to decide whether blood-thinning treatment — anticoagulation — should be considered. Doses, drug choices, and treatment thresholds belong on the [AFib treatment page](/atrial_fibrillation/treatment), because those decisions need clinician-level context and shouldn't be copied from a general guide.

Can AFib be dangerous? Life expectancy and "can it kill you"

AFib can feel frightening, especially when your heart suddenly races, flutters, or beats out of rhythm. The honest answer is: an AFib episode, by itself, is usually not immediately deadly — but AFib is still a serious condition because of what it can set up inside the body if it is not checked and managed. When the upper chambers of the heart quiver instead of squeezing cleanly, blood can pool, clots can form, and a clot can travel to the brain and cause a stroke. AFib is also linked with heart failure and other heart-related complications, especially when the rhythm or rate stays poorly controlled over time (American Heart Association: FAQ About AFib).

That is why "can AFib kill you?" has a nuanced answer. AFib itself is rarely the sudden cause; the dangerous part is the higher risk of complications such as stroke or heart failure. The CDC notes that AFib is associated with an approximately fivefold higher risk of ischemic stroke after accounting for standard stroke risk factors, and the American Heart Association emphasizes that untreated AFib is associated with higher stroke risk and heart-related death risk (CDC).

There is no single atrial fibrillation life expectancy number that applies to everyone. Your outlook depends on your age, blood pressure, other heart conditions, diabetes, sleep apnea, kidney disease, prior stroke history, symptoms, and how consistently AFib is followed. Some people have short episodes that come and go; others have persistent or permanent AFib. Some feel every beat; others have no symptoms at all. That is why a clinician estimates your personal risk rather than giving a generic "years left" answer (Mayo Clinic).

With medical care, many people live long, active lives with AFib. A typical care plan focuses on controlling how fast or irregularly the heart is beating, deciding whether rhythm control is appropriate, and reducing stroke risk when a person's risk profile calls for it. NICE guidelines describe AFib care as including stroke prevention, rate control, symptom assessment for rhythm control, and regular review; the NHS similarly notes that treatment can help manage symptoms and lower the risk of complications such as clots, stroke, and heart failure (NICE guideline NG196).

So yes, you can live with AFib for 20 years or longer — many people do — but the safest version of that future is not "ignore it and hope." It is: confirm the rhythm with an ECG, understand your stroke risk, keep follow-up appointments, and get urgent care if AFib comes with chest pain, fainting, severe shortness of breath, one-sided weakness, confusion, trouble speaking, or sudden vision changes.

How AFib is diagnosed

AFib is diagnosed by recording the heart's electrical activity, not by how the heartbeat feels in your chest and not by a wellness app. The main test is an ECG/EKG (electrocardiogram): sticky sensors on your chest and limbs record the timing and pattern of each beat, so a clinician can see whether the upper chambers of the heart are firing in the chaotic AFib pattern. It is the gold-standard first step, but it only captures what your rhythm is doing during that short recording. If your AFib comes and goes, a normal ECG in the clinic does not always mean "nothing happened." Mayo Clinic describes ECG as the main test for diagnosing AFib, and the American Heart Association explains that an EKG measures the electrical activity that controls heart rhythm (Mayo Clinic: Diagnosis & treatment).

That is why clinicians often use longer monitoring when symptoms are intermittent. A Holter monitor is a small portable ECG device worn during normal life, often for a day or two. An event monitor or patch monitor can be worn longer — sometimes for days to weeks — so it has a better chance of catching paroxysmal AFib, the kind that starts and stops. If episodes are rare, unexplained, or linked to fainting or a stroke evaluation, a clinician may consider an implantable loop recorder, a small device placed under the skin that continuously tracks heart rhythm for long-term monitoring in select cases. NICE guidance also supports ambulatory ECG monitoring when suspected paroxysmal AFib is not captured on a standard ECG, with monitor choice depending on how often symptoms occur (Mayo Clinic: Holter monitor).

Consumer wearables sit in a different category. An Apple Watch or another heart rate monitor watch for AFib may flag an irregular rhythm, and some devices can record a single-lead ECG that you can share with a clinician. That can be useful as a prompt to get checked, especially if the alert lines up with palpitations, shortness of breath, dizziness, unusual fatigue, or a racing heartbeat. But a wearable alert is not the same thing as a diagnosis. The 2023 ACC/AHA/ACCP/HRS AFib guideline lists handheld ECGs and smartwatches among monitoring options, while also stating that photoplethysmography-based irregular rhythm algorithms are not reliable enough on their own to establish an AFib diagnosis (2023 ACC/AHA/ACCP/HRS guideline).

Research context: wearable single-lead ECG devices "have become valuable tools for identifying paroxysmal atrial fibrillation (AF)" (*Frontiers in Cardiovascular Medicine*, 2025, PMC12537692) — but confirmation and treatment decisions are made by a clinician using diagnostic ECG evidence, your symptoms, your medical history, and your stroke-risk profile. If you want the deeper "what the tracing actually shows" explanation, see our [ECG/EKG guide](/ekg-ecg/).

When to see a doctor / when to call 911

Call 911 or emergency services right away if an irregular, pounding, or racing heartbeat comes with chest pain or pressure, fainting or nearly fainting, severe shortness of breath, or signs of stroke. Stroke signs can look like sudden face drooping, arm weakness, or speech trouble — the FAST rule means Face, Arm, Speech, and Time to call 911. Sudden confusion, trouble seeing, trouble walking, loss of balance, or a sudden severe headache can also be stroke warning signs, and fast treatment matters because every minute counts (CDC: Signs and Symptoms of Stroke).

See a doctor promptly, even if it does not feel like an emergency, if you notice a new, persistent, or recurring irregular pulse; episodes where your heart feels very fast, fluttery, or "off"; unexplained palpitations; new breathlessness; dizziness; unusual fatigue; or a drop in your usual exercise tolerance. AFib can come and go, and some people feel little or nothing, so the practical next step is to ask about an ECG/EKG or another clinician-recommended heart rhythm monitor. An ECG is the main test used to diagnose atrial fibrillation (Mayo Clinic).

If you can feel an irregular pulse — or a watch, ring, or other device flags an irregular rhythm — treat that as a reason to get checked, not as proof that you have AFib. Consumer devices can be useful prompts, but AFib is a medical diagnosis, and a clinician needs ECG evidence to confirm what rhythm your heart is actually in (Mayo Clinic: Diagnosis & treatment).

How Welltory fits

Welltory fits best as context, not as an atrial fibrillation test. It is not a medical device and does not detect, diagnose, or rule out AFib. It measures heart rate and heart rate variability optically, using PPG, so it can help you see how your pulse and body state change with sleep, activity, rest, stress, alcohol, illness, or recovery over time. But PPG looks at pulse patterns from blood-flow changes; it is not the same as recording the heart's electrical activity. The 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline says PPG can alert someone to get an ECG tracing, but it is not reliable enough by itself to establish an AFib diagnosis; an initial AFib diagnosis should be confirmed by a clinician reviewing electrocardiographic signals (2023 ACC/AHA/ACCP/HRS guideline).

So if you notice an irregular pulse, a suddenly fast heart rate that does not make sense for what you are doing, or a pattern that feels different from your usual baseline — whether you see it in Welltory, on a wearable, or just feel it in your chest — treat that as a reason to talk with a clinician and ask whether you need an ECG or heart-rhythm monitor. Welltory can help you bring a clearer story to that visit: when the episode happened, what your heart rate was doing, how you felt, and what was going on around it. It cannot confirm AFib, and it cannot reassure you that AFib is absent. Research on PPG-based tools shows they may be useful for screening or rhythm prompts, but ECG remains the reference test used for confirmation (PubMed 34775555).

How We Made It

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

We built this article from verified scientific excerpts, guideline-based framing (2023 ACC/AHA/ACCP/HRS and NICE NG196), and patient-education principles. We kept population-specific findings tied to the populations studied — for example, the Framingham lifetime-risk estimate reflects that cohort, and lifetime-risk ranges differ across populations in the guideline.

This article is educational and does not provide diagnosis. Welltory is not a medical device and does not detect or diagnose atrial fibrillation. For confirmation of any heart rhythm, an ECG interpreted by a clinician is required.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data